Abstract | BACKGROUND: PATIENTS: We present three children with nondystrophic myotonias. RESULTS: CONCLUSIONS: Based on this clinical experience and the favorable pharmacologic profile of acetazolamide, it may be a good treatment option for children with nondystrophic myotonias.
|
Authors | Joekie M Markhorst, Bas C Stunnenberg, Ieke B Ginjaar, Gea Drost, Corrie E Erasmus, Lilian T L Sie |
Journal | Pediatric neurology
(Pediatr Neurol)
Vol. 51
Issue 4
Pg. 537-41
(Oct 2014)
ISSN: 1873-5150 [Electronic] United States |
PMID | 25042881
(Publication Type: Case Reports, Journal Article)
|
Copyright | Copyright © 2014 Elsevier Inc. All rights reserved. |
Chemical References |
- Carbonic Anhydrase Inhibitors
- Acetazolamide
|
Topics |
- Acetazolamide
(administration & dosage, pharmacology)
- Adolescent
- Carbonic Anhydrase Inhibitors
(administration & dosage, pharmacology)
- Child
- Female
- Humans
- Male
- Myotonia
(diagnosis, drug therapy)
- Treatment Outcome
|